Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression speed of Alzheimer's disease.

A study found soybean oil contributed to obesity in mice, prompting concern about its use as America's most popular cooking oil.

Results showed that people with obesity had blood biomarkers for Alzheimer’s that rose more rapidly, including: Tau proteins, which form toxic clumps in the brains of Alzheimer’s patients. Protein fragments of neurofilament light chain (NfL), which are released from damaged or dying brain cells.

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment. In STEP UP, adults with obesity lost an average 18.7% of their body weight with the 7.2-mg dose. State Medicaid officials are grappling with whether to cover pricey GLP-1 drugs for weight loss. ( Politico)

Recent research has highlighted other health concerns related to cooking oils. Deep frying at high temperatures, particularly with reused oils, increases the production of toxic compounds—including acrylamide, trans fats, and peroxides—that have been linked to metabolic disorders, cancer, and even neurodegeneration in animal studies.

New research links America's most popular cooking oil to obesity through metabolic pathways that convert fatty acids into weight-promoting compounds.

A recent study revealed that obesity may accelerate the progression of Alzheimer’s disease.Scientists discovered that blood markers associated with Alzheimer’s increased nearly twice as fast in people with obesity in contrast to